Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

ADDITIONAL INFORMATION TO PROFIT OR LOSS ITEMS - Disclosure of detailed information about assets and liabilities (Details)

v3.26.1
ADDITIONAL INFORMATION TO PROFIT OR LOSS ITEMS - Disclosure of detailed information about assets and liabilities (Details) - CAD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Apr. 15, 2024
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS:          
Cash $ 2,727 $ 863   $ 1,813 $ 2,449
Trade receivables 10,848 13,803      
Other current assets 4,316 5,419      
Inventory 4,268 3,215      
Total current assets 22,741 23,364      
NON-CURRENT ASSETS:          
Property, plant and equipment, net 3,711 3,730      
Right-of-use assets, net 401 451      
Intangible assets, net 1,222 3,333      
Goodwill 1,885 6,679      
Total non-current assets 8,995 15,824      
Total assets 31,736 39,188      
CURRENT LIABILITIES:          
Trade payables 12,055 11,159      
Current maturities of operating lease liabilities 322 262      
Total current liabilities 34,006 34,918      
NON-CURRENT LIABILITIES:          
Operating lease liabilities 54 171      
Deferred tax liability, net 355 487      
Total non-current liabilities 1,345 1,124      
Total liabilities $ 35,351 $ 36,042      
Oranim Plus Pharm LTD. [Member]          
CURRENT ASSETS:          
Cash     $ 346    
Trade receivables     1,324    
Other current assets     759    
Inventory     837    
Total current assets     3,266    
NON-CURRENT ASSETS:          
Property, plant and equipment, net     783    
Right-of-use assets, net     533    
Intangible assets, net     1,414    
Goodwill     3,499    
Total non-current assets     6,229    
Total assets     9,495    
CURRENT LIABILITIES:          
Trade payables     1,597    
Other current liabilities     166    
Current maturities of operating lease liabilities     155    
Total current liabilities     1,918    
NON-CURRENT LIABILITIES:          
Operating lease liabilities     372    
Deferred tax liability, net     326    
Total non-current liabilities     698    
Total liabilities     2,616    
Purchase consideration payable     2,172    
Put option liability     $ 1,973